BlackRock Institutional Trust’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$13M Buy
214,908
+22,569
+12% +$1.38M ﹤0.01% 2245
2016
Q3
$12.8M Buy
192,339
+3,163
+2% +$198K ﹤0.01% 2184
2016
Q2
$10.6M Sell
189,176
-1,831
-1% -$89K ﹤0.01% 2259
2016
Q1
$6.43M Sell
191,007
-376
-0.2% -$12.8K ﹤0.01% 2532
2015
Q4
$8.64M Buy
191,383
+4,269
+2% +$184K ﹤0.01% 2424
2015
Q3
$7.39M Sell
187,114
-60,845
-25% -$3.46M ﹤0.01% 2486
2015
Q2
$15.4M Buy
247,959
+2,993
+1% +$178K ﹤0.01% 2102
2015
Q1
$15.3M Buy
244,966
+994
+0.4% +$60.5K ﹤0.01% 2115
2014
Q4
$13.8M Sell
243,972
-84,214
-26% -$3.71M ﹤0.01% 2162
2014
Q3
$9.28M Buy
328,186
+43,850
+15% +$1.31M ﹤0.01% 2387
2014
Q2
$9.79M Buy
284,336
+59,839
+27% +$1.88M ﹤0.01% 2450
2014
Q1
$7.04M Sell
224,497
-8,570
-4% -$227K ﹤0.01% 2622
2013
Q4
$4.68M Buy
233,067
+11,365
+5% +$147K ﹤0.01% 2815
2013
Q3
$2.17M Buy
221,702
+13,497
+6% +$97.3K ﹤0.01% 3092
2013
Q2
$1.25M Buy
+208,205
New +$1.46M ﹤0.01% 3267

Other funds holding ANIP